Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. 1985

S D Semrad, and G E Hardee, and M M Hardee, and J N Moore

The pharmacokinetics and inhibition of prostaglandin synthesis in conscious horses given various dosages of flunixin meglumine were studied. Plasma concentrations of flunixin were measured by high-performance liquid chromatography, and serum thromboxane B2 and 6-keto prostaglandin F1 alpha were quantitated by radioimmunoassay. Within the dosage range studied, linear pharmacokinetics were achieved. After IV administration of flunixin (1.1 mg/kg, 0.25 mg/kg, 0.1 mg/kg), significant suppression of serum thromboxane generation persisted for 12, 4, and 3 hours, respectively. Repeated administrations of flunixin (0.25 mg/kg) once every 8 hours maintained significant suppression of thromboxane generation for the duration of treatment. After treatment with flunixin was stopped, serum thromboxane generation exceeded base line (pretreatment values). Among the groups, significant alteration of 6-keto prostaglandin F1 alpha production was not observed.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009539 Nicotinic Acids 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin. Acids, Nicotinic
D011448 Prostaglandin Antagonists Compounds that inhibit the action of prostaglandins. Prostaglandin Inhibitors,Antagonists, Prostaglandin,Inhibitors, Prostaglandin,Prostaglandin Antagonist,Prostaglandin Inhibitor,Antagonist, Prostaglandin,Inhibitor, Prostaglandin
D003002 Clonixin Anti-inflammatory analgesic. CBA-93626,Sch-10304,CBA 93626,CBA93626,Sch 10304,Sch10304
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013929 Thromboxane B2 A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). B2, Thromboxane

Related Publications

S D Semrad, and G E Hardee, and M M Hardee, and J N Moore
November 1999, American journal of veterinary research,
S D Semrad, and G E Hardee, and M M Hardee, and J N Moore
August 1985, American journal of veterinary research,
S D Semrad, and G E Hardee, and M M Hardee, and J N Moore
September 2021, Journal of veterinary pharmacology and therapeutics,
S D Semrad, and G E Hardee, and M M Hardee, and J N Moore
January 1985, American journal of veterinary research,
S D Semrad, and G E Hardee, and M M Hardee, and J N Moore
June 2004, Journal of veterinary pharmacology and therapeutics,
S D Semrad, and G E Hardee, and M M Hardee, and J N Moore
February 2014, Journal of veterinary pharmacology and therapeutics,
S D Semrad, and G E Hardee, and M M Hardee, and J N Moore
September 1983, American journal of veterinary research,
S D Semrad, and G E Hardee, and M M Hardee, and J N Moore
November 1988, American journal of veterinary research,
S D Semrad, and G E Hardee, and M M Hardee, and J N Moore
June 2018, Journal of veterinary pharmacology and therapeutics,
S D Semrad, and G E Hardee, and M M Hardee, and J N Moore
July 1985, Research in veterinary science,
Copied contents to your clipboard!